NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIEHS E-056-1998-1-US-02 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US DIV 08/850,062 Abandoned
NIEHS E-056-1998-1-US-03 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US FWC 08/850,142 Abandoned
NIEHS E-056-1998-0-US-01 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US CIP 08/850,085 Expired
NIEHS E-056-1998-1-US-01 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US CON 08/848,962 Abandoned
NCI E-157-1997-0-US-01 IMMUNOTOXINS DIRECTED AGAINST MALIGNANT B CELLS US 60/046,895 Abandoned
NIDDK E-058-2000-0-US-01 Mass Spectrometry of Colonization Factors US 60/045,511 Abandoned
NIAID E-146-1997-0-US-01 Pvs28, A VACCINE CANDIDATE FOR BLOCKING TRANSMISSION OF PLASMODIUM VIVAX US 60/045,283 Abandoned
NICHD E-016-1996-0-CA-04 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS CA National Stage 2253673 Expired
NICHD E-016-1996-0-JP-07 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS JP National Stage 9-539232 Expired
NICHD E-016-1996-0-MX-08 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS MX National Stage 989124 Expired
NICHD E-016-1996-0-ES-18 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS ES EP 97923523.1 Expired
NICHD E-016-1996-0-SE-20 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS SE EP 97923523.1 Expired
NICHD E-016-1996-0-CH-17 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS CH EP 97923523.1 Expired
NICHD E-016-1996-0-PT-23 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS PT EP 97923523.1 Expired
NICHD E-016-1996-0-IE-22 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS IE EP 97923523.1 Expired
NICHD E-016-1996-0-IT-12 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS IT EP 97923523.1 Expired
NICHD E-016-1996-0-DK-14 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS DK EP 97923523.1 Expired
NICHD E-016-1996-0-FI-21 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS FI EP 97923523.1 Expired
NICHD E-016-1996-0-GB-11 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS GB EP 97923523.1 Expired
NICHD E-016-1996-0-NL-19 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS NL EP 97923523.1 Expired
NICHD E-016-1996-0-GR-15 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS GR EP 3034562 Expired
NICHD E-016-1996-0-FR-10 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS FR EP 97923523.1 Expired
NICHD E-016-1996-0-DE-09 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS DE EP 97923523.1 Expired
NICHD E-016-1996-0-BE-13 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS BE EP 97923523.1 Expired
NICHD E-016-1996-0-AT-16 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS AT EP 97923523.1 Expired
NICHD E-016-1996-0-EP-05 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS EP National Stage 97923523.1 Expired
NICHD E-016-1996-0-AU-03 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS AU National Stage 29304/97 Expired
NICHD E-016-1996-0-PCT-02 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS PCT PCT PCT/US1997/007373 Expired
NICHD E-016-1996-0-CA-27 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS CA DIV 2668824 Abandoned
NCI E-006-2000-0-US-01 RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS US 60/045,176 Abandoned
NCI E-194-1994-2-US-01 SUBSTITUTED O6-BENZYLGUANINES,COMPOSITIONS, AND METHODS OF USING SAME US CIP 08/849,223 5958932 Abandoned PDF
CC E-020-1996-1-US-02 IMAGE REGISTRATION USING CLOSEST CORRESPONDING VOXELS WITH AN ITERATIVE REGISTRATION PROCESS US ORD 08/847,733 5937083 Abandoned PDF
CC E-020-1996-1-PCT-01 IMAGE REGISTRATION USING VOXEL GRADIENTS WITH AN ITERATIVE REGISTRATION PROCESS PCT PCT COMB PCT/US1997/007168 Expired
NCI E-058-1996-0-PCT-02 NUCLEIC ACID MOLECULES ENCODING THE TRANSCRIPTIONAL REPRESSOR GCF2 PCT PCT PCT/US1997/007172 Expired
NCI E-163-1997-0-US-01 IDENTIFICATION OF SMALL MOLECULE INHIBITORS OF CYCLIN DEPENDENT KINASE (CDK) 4 US 60/044,256 Abandoned
NIDCD E-228-1995-1-US-01 CONJUGATE VACCINE FOR NONTYPEABLE HAEMOPHILUS INFLUENZAE US CIP 08/842,409 6207157 Expired PDF
NCI E-196-1992-3-US-17 Biopolymer-Bound Nitric Oxide-Releasing Compositions, Incorporating Same and Methods of Treating Biological Disorders Using Same US DIV 08/837,812 6200558 Abandoned PDF
NCI E-087-1996-0-PCT-02 HETEROLOGOUS BOOSTING IMMUNIZATIONS FOR THE GENERATION OF CTL AND ANTITUMOR RESPONSES PCT PCT PCT/US1997/006632 Expired
NIDDK E-195-1998-0-US-01 RNase L Activators and Antisense Oligonucleotides Effective to Treat Telomerase-Expressing Malignances US 60/044,507 Abandoned
NCI E-087-1996-0-CA-03 HETEROLOGOUS BOOSTING IMMUNIZATIONS CA National Stage 2252406 Abandoned
NIAID E-082-1996-0-PCT-02 SIMIAN-HUMAN HAV CHIMERAS ENCODING A HEPATITIS A VIRUS HAVING A CHIMERIC 2C PROTEIN PCT PCT PCT/US1997/006506 Expired
NIAID E-082-1996-0-CA-03 SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN CA National Stage 2251832 Abandoned
NIAID E-082-1996-0-JP-05 SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN JP National Stage 538204/97 Abandoned
NIAID E-082-1996-0-EP-06 SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN EP National Stage 97923424.2 Abandoned
NIAID E-082-1996-0-AU-04 SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN AU National Stage 29232/97 Abandoned
NCI E-088-1996-0-CH-11 POINT MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES CH EP 97921247.9 Abandoned
NCI E-088-1996-0-ES-10 MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES ES EP 97921247.9 Abandoned
NCI E-088-1996-0-NL-09 MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES NL EP 97921247.9 Abandoned
NCI E-088-1996-0-IT-08 MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES IT EP 97921247.9 Abandoned
NCI E-088-1996-0-DK-04 MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES DK EP 97921247.9 Abandoned